Bleeding Disorders a Scare or Properly Reassured

Authors

  • Dr. Namballa Naveen, M.B.B.S. Internal Medicine, California Institute of Behavioural Neuroscience and Psychology, Fairfield, California, USA Emergency Medicine, Steel Authority Of India (SAIL) hospital, Chasnalla, Dhanbad, India ,

DOI:

https://doi.org/10.56570/jimgs.v2i1.101

Keywords:

Haemorrhage, Bleeding disorders, differentiation, diagnosis, prognosis

Abstract

In an attempt to distinguish between ALL, CML, CLL, AML, ITP, DIC, hemophilia A, hemophilia B, von Willebrand disease, Microangiopathic Hemolytic Anemia, Bernard-Soulier syndrome, Glanzmann thrombasthenia, Vitamin K deficiency, Heparin-induced thrombocytopenia, Coagulation Factor Inhibitor, and Factor 5 Leiden, might influence the decision to work as a consultant clinical pathologist. Since most patients with bleeding disorders are at risk for post-surgical bleeding, CNS bleeding, post-trauma bleeding, nosebleeds (epistaxis), death from liver illness (hemorrhage), etc., it might become challenging for med school students or junior doctors to diagnose. When performing any type of invasive or non-invasive procedure, including emergency or elective surgery, hospitals, clinics, and the relevant junior doctors and medical students must treat these illnesses as the primary focus of care and conduct routine blood tests, platelet count, PT, PTT, hemoglobin, bleeding time, and, if necessary, a bone marrow biopsy. An abnormal ristocetin test (for Von Willebrand disease) and a D-dimer test (for DIC) can be considered. It needs proper interpretation with a strong command of concepts, evaluation, and then diagnosis.

References

Payne AB, Ghaji N, Mehal JM, et al. Mortality Trends and Causes of Death in Persons with Hemophilia in the United States, 1999-2014. Blood. 2017;130(Suppl_1):755-755. doi:10.1182/blood.V130.Suppl_1.755.755

Mansouritorghabeh H, Rahimi H, Mohades ST, Behboudi M. Causes of Death Among 379 Patients With Hemophilia: A Developing Country’s Report. Clinical and Applied Thrombosis/Hemostasis. 2018;24(4):612-617. doi:10.1177/1076029617713873

Sonneveld MAH, Franco OH, Ikram MA, et al. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality. Arterioscler Thromb Vasc Biol. 2016;36(12):2446-2451. doi:10.1161/ATVBAHA.116.308225

Costello RA, Nehring SM. Disseminated Intravascular Coagulation.; 2023. http://www.ncbi.nlm.nih.gov/pubmed/30776686

KITCHENS CS. To bleed or not to bleed? is that the question for the PTT? Journal of Thrombosis and Haemostasis. 2005;3(12):2607-2611. doi:10.1111/j.1538-7836.2005.01552.x

Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts. Arch Intern Med. 2000;160(11):1630. doi:10.1001/archinte.160.11.1630

James AH. Bleeding Disorders in Adolescents. Obstet Gynecol Clin North Am. 2009;36(1):153-162. doi:10.1016/j.ogc.2008.12.002

JAMES AH. Women and bleeding disorders. Haemophilia. 2010;16:160-167. doi:10.1111/j.1365-2516.2010.02315.

Downloads

Published

2023-06-13

Issue

Section

Articles

How to Cite

1.
Naveen N. Bleeding Disorders a Scare or Properly Reassured. Journal For International Medical Graduates. 2023;2(1). doi:10.56570/jimgs.v2i1.101